Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
[oral submucous fibrosis]
Angiogenesis
and
the
acquisition
of
an
angiogenic
phenotype
is
important
for
cancer
cell
proliferation
.
Copper
in
an
essential
trace
element
that
participates
in
many
enzymatic
complexes
like
the
cytochrome
c
,
superoxide
dismutase
and
lysyl
oxidase
and
it
is
involved
in
processes
,
like
embryogenesis
,
growth
,
angiogenesis
and
carcinogenesis
.
In
particular
,
its
involvement
in
carcinogenesis
was
described
for
the
first
time
in
oral
submucous
fibrosis
,
where
fibroblasts
produce
large
amounts
of
collagen
in
the
presence
of
copper
.
Copper
's
action
in
carcinogenesis
is
two-fold
:
(
1
)
it
participates
in
reactions
with
an
increased
redox
potential
that
result
in
the
production
of
oxidative
products
and
oxidative
stress
.
Through
this
mechanism
,
copper
may
cause
DNA
mutations
in
the
nucleus
and
mitochondria
or
alterations
to
membrane
phospholipids
,
(
2
)
it
participates
in
angiogenesis
even
in
the
absence
of
angiogenic
molecules
,
as
it
was
reported
for
the
first
time
in
rabbit
cornea
models
with
copolymer
pellets
charged
with
PGE
1
.
Copper
chelation
regimens
like
penicillamine
and
tetrathiomolybdate
are
being
described
in
the
literature
as
having
anti-angiogenic
,
anti-fibrotic
and
anti-
inflammatory
actions
.
Animal
models
of
brain
cancer
that
evaluated
the
anti-angiogenic
properties
of
copper
,
have
proven
evidence
of
the
reduction
of
tumor
's
microvascular
supply
,
tumor
volume
and
vascular
permeability
after
plasma
copper
levels
reduction
.
Interestingly
,
plasma
copper
levels
reduction
was
shown
to
suppress
micrometastases
generation
in
mice
models
of
breast
cancer
.
We
hypothesize
that
copper
chelation
therapy
:
increases
oxidative
stress
in
cancer
cells
to
a
level
that
does
not
allow
survival
because
of
the
reduction
of
anti-oxidative
enzymes
production
.
It
may
also
result
in
inhibition
of
angiogenesis
and
of
the
initiation
of
the
angiogenic
switch
,
because
copper
normally
enhances
endothelial
cell
migration
and
proliferation
,
improves
binding
of
growth
factors
to
endothelial
cells
and
enhances
the
expression
of
angiogenic
molecules
.
Copper
chelation
may
also
reduce
extracellular
matrix
degradation
and
cancer
spread
,
through
reduction
of
MMP-
9
production
and
probably
of
other
collagenases
and
may
inhibit
propagation
of
micrometastases
.
However
,
copper
chelation
therapy
may
enhance
angiogenesis
through
reduction
of
thrombospondin-
1
,
that
results
into
an
increase
in
VEGF-VEGFR
2
complexes
and
a
high
level
of
active
MMP-
9
.
These
hypotheses
help
in
understanding
of
the
anti-angiogenic
action
of
copper
chelation
therapies
and
of
the
complex
network
of
interactions
between
copper
and
other
molecules
involved
in
angiogenesis
.
It
may
also
stimulate
further
research
regarding
differences
in
copper
metabolism
,
the
effects
of
anti-copper
regimens
on
organs
,
the
development
of
resistance
,
and
their
possible
angiogenic
action
through
thrombospondin
expression
reduction
.
Diseases
Validation
Diseases presenting
"where fibroblasts produce large amounts of collagen in the presence of copper"
symptom
oral submucous fibrosis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom